MX170454B - Una composicion para cicatrizacion de heridas y regeneracion de huesos y metodo para prepararla - Google Patents

Una composicion para cicatrizacion de heridas y regeneracion de huesos y metodo para prepararla

Info

Publication number
MX170454B
MX170454B MX009367A MX936787A MX170454B MX 170454 B MX170454 B MX 170454B MX 009367 A MX009367 A MX 009367A MX 936787 A MX936787 A MX 936787A MX 170454 B MX170454 B MX 170454B
Authority
MX
Mexico
Prior art keywords
preparing
composition
wound healing
bone regeneration
mammal
Prior art date
Application number
MX009367A
Other languages
English (en)
Spanish (es)
Inventor
Harry N Antoniades
Ray C Williams
Samuel E Lynch
Original Assignee
Inst Molecular Biology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Molecular Biology Inc filed Critical Inst Molecular Biology Inc
Publication of MX170454B publication Critical patent/MX170454B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX009367A 1986-11-14 1987-11-16 Una composicion para cicatrizacion de heridas y regeneracion de huesos y metodo para prepararla MX170454B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93076286A 1986-11-14 1986-11-14

Publications (1)

Publication Number Publication Date
MX170454B true MX170454B (es) 1993-08-24

Family

ID=25459724

Family Applications (1)

Application Number Title Priority Date Filing Date
MX009367A MX170454B (es) 1986-11-14 1987-11-16 Una composicion para cicatrizacion de heridas y regeneracion de huesos y metodo para prepararla

Country Status (15)

Country Link
EP (1) EP0289584B1 (enExample)
JP (1) JPH01500199A (enExample)
KR (1) KR960005708B1 (enExample)
CN (1) CN1027346C (enExample)
AT (1) ATE88899T1 (enExample)
AU (1) AU600069B2 (enExample)
DE (1) DE3785758T2 (enExample)
DK (1) DK175889B1 (enExample)
IE (1) IE60517B1 (enExample)
MX (1) MX170454B (enExample)
NO (1) NO883127L (enExample)
NZ (1) NZ222551A (enExample)
OA (1) OA09159A (enExample)
WO (1) WO1988003409A1 (enExample)
ZA (1) ZA878566B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889919A (en) * 1986-08-13 1989-12-26 Zymogenetics, Inc. Biologically active PDGF derived A-chain homodimers
US5474982A (en) * 1986-08-13 1995-12-12 Zymogenetics, Inc. PDGF analogs and methods of use
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
ZA9010332B (en) * 1989-12-22 1991-08-28 Ciba Geigy Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
CA2060208C (en) * 1990-04-10 2001-02-20 Harry N. Antoniades Wound healing
JP3377524B2 (ja) * 1990-05-30 2003-02-17 プレジデント アンド フェロウズ オブ ハーバード カレッジ 創傷治癒
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
WO1993008825A1 (en) * 1991-11-04 1993-05-13 Zymogenetics, Inc. Pdgf gel formulation
FR2691911B1 (fr) * 1992-06-05 1994-11-25 Delmas Olivier Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.
AU670951B2 (en) * 1992-06-08 1996-08-08 Chiron Corporation Use of growth factor IGF-I and/or IGF-II
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
CN1055023C (zh) * 1993-01-03 2000-08-02 周至譓 伤口护理剂
EP0691849B1 (en) * 1993-03-29 1999-06-02 ZymoGenetics, Inc. Oesteoblast growth stimulating compostion containing pdgf and vitamin d
DE69431534T2 (de) 1994-07-12 2003-06-26 Human Genome Sciences Inc Bindegewebswachstumsfaktor-2
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
EP1486565B1 (en) * 1995-10-11 2007-11-21 Novartis Vaccines and Diagnostics, Inc. Combination of PDGF, KGF, IGF, and IGFBP for wound healing
EP0948538B1 (en) 1996-12-13 2008-06-11 Novartis Vaccines and Diagnostics, Inc. Analysis and separation of platelet-derived growth factor proteins
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7241874B2 (en) 2002-06-26 2007-07-10 Zimmer Ortho Biologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
KR20080084808A (ko) 2005-11-17 2008-09-19 바이오미메틱 세라퓨틱스, 인크. ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
EP2311505B1 (en) 2006-02-09 2013-11-06 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
EP3381463A1 (en) 2006-06-30 2018-10-03 BioMimetic Therapeutics, LLC Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
CA2668189C (en) 2006-11-03 2016-01-26 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures comprising a solution of platelet derived growth factor (pdgf) incorporated in a biocompatible matrix
CN102014977B (zh) 2008-02-07 2015-09-02 生物模拟治疗有限责任公司 用于牵引成骨术的组合物和方法
CN102231992B (zh) 2008-09-09 2015-05-20 生物模拟治疗公司 用于治疗肌腱和韧带损伤的血小板衍生生长因子的组合物和方法
NZ601559A (en) 2010-02-22 2014-10-31 Biomimetic Therapeutics Llc Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
CN102397534B (zh) * 2010-09-07 2013-10-23 中国人民解放军总医院 胰岛素在制备促进颌骨组织愈合的药物中的用途
WO2013077641A1 (ko) * 2011-11-22 2013-05-30 (주)아모레퍼시픽 성장 인자를 포함하는 피부 재생 촉진제
JP6871855B2 (ja) 2014-10-14 2021-05-19 サムエル リンチ， 創傷を処置するための組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor

Also Published As

Publication number Publication date
EP0289584A4 (en) 1990-01-08
WO1988003409A1 (en) 1988-05-19
NZ222551A (en) 1989-11-28
EP0289584A1 (en) 1988-11-09
DE3785758D1 (de) 1993-06-09
NO883127D0 (no) 1988-07-13
IE60517B1 (en) 1994-07-27
EP0289584B1 (en) 1993-05-05
AU600069B2 (en) 1990-08-02
NO883127L (no) 1988-09-12
JPH01500199A (ja) 1989-01-26
CN1027346C (zh) 1995-01-11
KR960005708B1 (ko) 1996-05-01
DE3785758T2 (de) 1993-08-05
IE873075L (en) 1988-05-14
DK393288A (da) 1988-09-13
ATE88899T1 (de) 1993-05-15
OA09159A (en) 1992-03-31
CN87101250A (zh) 1988-06-08
DK175889B1 (da) 2005-05-30
AU8328987A (en) 1988-06-01
JPH0581569B2 (enExample) 1993-11-15
ZA878566B (en) 1989-07-26
DK393288D0 (da) 1988-07-14
KR890700033A (ko) 1989-03-02

Similar Documents

Publication Publication Date Title
MX170454B (es) Una composicion para cicatrizacion de heridas y regeneracion de huesos y metodo para prepararla
ATE109352T1 (de) Heilung von wunden.
DK0479799T3 (da) Sårheling
MX164966B (es) Composicion para la cicatrizacion de heridas derivada de plaquetas y un factor alfa de crecimiento y metodo para prepararla
BR8603566A (pt) Composicao para o tratamento de tecidos
SE8204064D0 (sv) Gewebeklebstoff sowie verfahren zu dessen herstellung
ATE69376T1 (de) Haarwuchsmittel.
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
MX7309E (es) Metodo mejorado para la purificacion del factor antihemofilico humano
FI885224A7 (fi) Puhdistettu verihiutaleista peräisin oleva kasvutekijä ja menetelmiä s en puhdistamiseksi
DE68922671D1 (de) Verfahren zur Herstellung von Polyarylensulfiden.
BR8804161A (pt) Composicao aperfeicoada esterilizavel por radiacao
DE69431373D1 (de) Verfahren zur Herstellung von optisch aktiven 2-Amino-1-Phenylethanol-Derivaten
FI873599A7 (fi) Menetelmä ja seos luuvaurion parantamiseksi.
DE3775510D1 (de) Bindungsinduzierende komposition.
FI841161A7 (fi) Yhdiste ja koostumus terapeuttista tai diagnostista käyttöä varten sekä terapeuttinen hoitomenetelmä.
ATE222117T1 (de) Kombination aus igf-i und tgf-beta zur knochenregenerierung
FI896031A7 (fi) Kasvinkäsittelykoostumus
DE58909337D1 (de) Verfahren zur Herstellung von reinen 3-Butenyltriorganyloxysilanen.
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
AR240312A1 (es) Compuesto de 2-carboximetil-azetidina, procedimiento de preparacion y composicon para esterilizacion de anteras.
ATA250986A (de) Verfahren zur herstellung neuer, optisch aktiver tert.butylester der weinsaeure und einiger o,o-diacylderivate